Will be very irrational if DTZ post trading resuming will continue to trade at $90m mcap (eg 24c). With proven technology that was already approved by CE and with FDA submission coming, we should be trading at min $200m mcap even before commercial contracts commence for that. So another $100m add on to mcap is very logical. Puts us at 50c per share at minimum. Fast forward few quarters assuming DTZ will be succes
sful at getting few commercial contracts under its belt (which should see $$$ coming in much quicker given clients will pay on the spot for this) and we should be at $1 per share, conservatively. This puts us at fully diluted basis around $420m or US$300m. To me this is not a pie in the sky.
Will be very irrational if DTZ post trading resuming will...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DTZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.32M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.0¢ | 12.5¢ | $35.04K | 264.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 37667 | 1 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| DTZ (ASX) Chart |